Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|March 20, 2012
Impact of terminal dimethylation on the resistance profile of α-N-heterocyclic thiosemicarbazonesPetra Heffeter, Christine Pirker, Christian R Kowol, et al.
Oncotarget|April 27, 2012
Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulationVéronique Mathieu, Christine Pirker, Wolfgang M Schmidt, et al.
Communications Chemistry|January 25, 2023
A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistancePhilipp Fronik, Michael Gutmann, Petra Vician, et al.
Dalton Transactions (Cambridge, England : 2003)|July 2, 2026
Novel ruthenium(II) complexes bearing polypyridyl and 1,2,4-oxadiazole ligands: from synthesis to <i>in vitro</i> and <i>in vivo</i> anticancer evaluationLaura Marretta, Daniel Valcanover, Maria Pia Buono, et al.
Neuro-Oncology|February 13, 2010
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsSabine Spiegl-Kreinecker, Christine Pirker, Martin Filipits, et al.
Neuro-Oncology|February 15, 2015
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosisSabine Spiegl-Kreinecker, Daniela Lötsch, Bahil Ghanim, et al.
Cancer Genetics and Cytogenetics|October 14, 2003
Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapyBarbara Fazeny-Dörner, Maria Piribauer, Catharina Wenzel, et al.
Archives of Dermatological Research|July 31, 2014
MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastasesPeter Birner, Anna S Berghoff, Carina Dinhof, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|September 8, 2004
Whole genome amplification for CGH analysis: Linker-adapter PCR as the method of choice for difficult and limited samplesChristine Pirker, Maria Raidl, Elisabeth Steiner, et al.
Pathology Oncology Research : POR|March 10, 2015
Sensitivity of Melanoma Cells to EGFR and FGFR Activation but Not Inhibition is Influenced by Oncogenic BRAF and NRAS MutationsTamás Garay, Eszter Molnár, Éva Juhász, et al.
Pageof 9